West Pharmaceutical Services, Inc. (WST): Price and Financial Metrics
West Pharmaceutical Services, Inc. (WST)
Today's Latest Price: $277.96 USD
Updated Nov 27 1:03pm
Add WST to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
WST Stock Summary
- West Pharmaceutical Services Inc's market capitalization of $19,901,199,010 is ahead of 89.99% of US-listed equities.
- WST's went public 32.92 years ago, making it older than 89.5% of listed US stocks we're tracking.
- The price/operating cash flow metric for West Pharmaceutical Services Inc is higher than 91.13% of stocks in our set with a positive cash flow.
- If you're looking for stocks that are quantitatively similar to West Pharmaceutical Services Inc, a group of peers worth examining would be MKTX, FTNT, AKAM, LOGI, and TECH.
- Visit WST's SEC page to see the company's official filings. To visit the company's web site, go to www.westpharma.com.
WST Stock Price Chart Interactive Chart >
WST Price/Volume Stats
| Current price | $277.96 | 52-week high | $305.00 |
| Prev. close | $269.20 | 52-week low | $124.53 |
| Day low | $271.65 | Volume | 190,581 |
| Day high | $277.99 | Avg. volume | 586,395 |
| 50-day MA | $282.53 | Dividend yield | 0.25% |
| 200-day MA | $229.08 | Market Cap | 20.55B |
West Pharmaceutical Services, Inc. (WST) Company Bio
West Pharmaceutical Services develops, manufactures, and sells components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company operates through two segments, Pharmaceutical Packaging Systems and Pharmaceutical Delivery Systems. The company was founded in 1923 and is based in Exton, Pennsylvania.
WST Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $277.96 | $93.14 | -67% |
We started the process of determining a valid price forecast for West Pharmaceutical Services Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that West Pharmaceutical Services Inc ranked in the 23th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of West Pharmaceutical Services Inc, consider:
- Interest coverage, a measure of earnings relative to interest payments, is 47.38 -- which is good for besting 91.98% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
- The business' balance sheet reveals debt to be 1% of the company's capital (with equity being the remaining amount). Approximately merely 7.47% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- WST's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 50.53% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -68% |
| 1% | -68% |
| 2% | -67% |
| 3% | -67% |
| 4% | -67% |
| 5% | -66% |
MDT, CPIX, DHR, EHC, and RHE can be thought of as valuation peers to WST, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...